Delaying Second Pfizer COVID-19 Vaccine Dose Increases Antibody Response Threefold In Over-80s, Study Finds 14/05/2021 Madeleine Hoecklin Delaying the second dose of the Pfizer/BioNTech COVID-19 vaccine by 12 weeks could generate antibody responses in those over the age of 80 more than threefold, found a pre-print study published on Friday. The study, conducted by the University of Birmingham and Public Health England, is the first to directly compare the immune response derived […] Continue reading -> Tedros: COVID-19 Vaccination is ‘Bittersweet’ Amid Global Shortages 14/05/2021 Kerry Cullinan Being vaccinated against COVID-19 this week was a “bittersweet” moment, reflecting both a “triumph of science” and a “gross distortion” in vaccine access, World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyusus told the body’s media briefing on Friday. Thanking health workers at the Geneva Emergency Hospital for vaccinating him on Wednesday, Dr Tedros […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Nigeria Moves Ahead With Second AstraZeneca Dose In Move To Build Vaccine Immunity Among Highest Risk Groups 13/05/2021 Paul Adepoju IBADAN – The Nigerian government has decided to move ahead with a second dose of the AstraZeneca vaccine for the nearly 2 million citizens who already received the vaccine – despite advice from Africa CDC and the World Health Organization (WHO), that vaccine-strapped African countries could also choose to administer just one vaccine dose – […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Tedros: COVID-19 Vaccination is ‘Bittersweet’ Amid Global Shortages 14/05/2021 Kerry Cullinan Being vaccinated against COVID-19 this week was a “bittersweet” moment, reflecting both a “triumph of science” and a “gross distortion” in vaccine access, World Health Organization (WHO) Director General Dr Tedros Adhanom Ghebreyusus told the body’s media briefing on Friday. Thanking health workers at the Geneva Emergency Hospital for vaccinating him on Wednesday, Dr Tedros […] Continue reading -> Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Nigeria Moves Ahead With Second AstraZeneca Dose In Move To Build Vaccine Immunity Among Highest Risk Groups 13/05/2021 Paul Adepoju IBADAN – The Nigerian government has decided to move ahead with a second dose of the AstraZeneca vaccine for the nearly 2 million citizens who already received the vaccine – despite advice from Africa CDC and the World Health Organization (WHO), that vaccine-strapped African countries could also choose to administer just one vaccine dose – […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Draft ‘Rome Declaration’ by G-20 Global Health Summit – Sidesteps Hard Commitments to New COVID Finance & Vaccine Donations 14/05/2021 Elaine Ruth Fletcher A draft “Rome Declaration” to be issued at next Friday’s G-20’s Global Health Summit, co-hosted by Italy and the European Commission (21 May), makes a series of 10 sweeping commitments to ensure equitable access to vaccines; expand medicines manufacturing capacity; assure WHO access to sites posing an outbreak risk; and invest in global health systems. […] Continue reading -> Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Nigeria Moves Ahead With Second AstraZeneca Dose In Move To Build Vaccine Immunity Among Highest Risk Groups 13/05/2021 Paul Adepoju IBADAN – The Nigerian government has decided to move ahead with a second dose of the AstraZeneca vaccine for the nearly 2 million citizens who already received the vaccine – despite advice from Africa CDC and the World Health Organization (WHO), that vaccine-strapped African countries could also choose to administer just one vaccine dose – […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pandemic ‘Far From Over’ in the Americas; Vaccination Prompting a ‘False Sense of Security’ in the Region 14/05/2021 Raisa Santos Though more than 114 million people have been vaccinated against COVID-19 in the Americas, the WHO Pan American Health Organization (PAHO) has warned that the pandemic is far from over. Last week, the region reported more than 1.2 million new COVID-19 cases and nearly 34,000 COVID related deaths – nearly 40% of all global deaths […] Continue reading -> Nigeria Moves Ahead With Second AstraZeneca Dose In Move To Build Vaccine Immunity Among Highest Risk Groups 13/05/2021 Paul Adepoju IBADAN – The Nigerian government has decided to move ahead with a second dose of the AstraZeneca vaccine for the nearly 2 million citizens who already received the vaccine – despite advice from Africa CDC and the World Health Organization (WHO), that vaccine-strapped African countries could also choose to administer just one vaccine dose – […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Nigeria Moves Ahead With Second AstraZeneca Dose In Move To Build Vaccine Immunity Among Highest Risk Groups 13/05/2021 Paul Adepoju IBADAN – The Nigerian government has decided to move ahead with a second dose of the AstraZeneca vaccine for the nearly 2 million citizens who already received the vaccine – despite advice from Africa CDC and the World Health Organization (WHO), that vaccine-strapped African countries could also choose to administer just one vaccine dose – […] Continue reading -> Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global COVID-19 Vaccine Task Force Lays Out Plans To Scale Up Production and Fill US$18.5 Billion Gap 12/05/2021 Madeleine Hoecklin & Elaine Ruth Fletcher In a rush to jumpstart more global vaccine manufacturing capacity, the global COVAX vaccine facility is now stepping into the fray. A new COVAX Supply Chain and Manufacturing Task Force has laid out a three-stage plan to enhance existing vaccine production capacity, as well setting up a new “vaccine manufacturing group” – to further expand […] Continue reading -> Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sweeping Report on COVID Pandemic: Broken Global Emergency Alert System, Hesitant WHO & Patchy Country Responses 12/05/2021 Elaine Ruth Fletcher A sweeping report on the global pandemic response has found that the World Health Organization should have taken a more “precautionary’ approach to the emerging SARS-COV2 virus in the early days of the pandemic, advising countries earlier on that it could be transmitted person-to-person — rather than only warning of such a “possibility”. The report […] Continue reading -> Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Impact of COVID-19 on African Continent Underestimated, Says New Report 12/05/2021 Raisa Santos Limitations in COVID-19 testing capacity and surveillance—as well as uneven demand for testing—are likely masking the true severity of COVID-19 on the African continent, fueling the dangerous myth that much of Africa has been unscathed by COVID-19. Test positivity rates were above 10% across many African Union (AU) member states during the second wave—substantially higher […] Continue reading -> Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Company Pushes Canada to Grant Compulsory License for Johnson & Johnson COVID-19 Vaccine 11/05/2021 Kerry Cullinan A Canadian pharmaceutical company, Biolyse, has agreed to provide Bolivia with 15 million doses of the Johnson & Johnson COVID-19 vaccine – as long as the Canadian government gives it a compulsory license to manufacture the vaccine. In March, Johnson & Johnson rejected an application by Biolyse for a voluntary license to make a generic […] Continue reading -> WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Calls For Pharma Transparency In Clinical Trial Data Reporting 07/05/2021 Elaine Ruth Fletcher In a far-reaching statement, WHO and the International Coalition of Medicines Regulatory Authorities (ICMRA) called on the pharma industry to provide much wider access to clinical data for all new medicines and vaccines approved, or under review, and even those that had been rejected. “Clinical trial reports should be published without redaction of confidential information […] Continue reading -> Posts navigation Older postsNewer posts